A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Clinical trial NCT03178149 · RECRUITING
Trial details
- NCT number
- NCT03178149
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2026-06-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.